| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.18 | 0.5 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.04 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.08 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |